Find uplifting stories about heroes, innovations, and solutions
35 results for "insulin"
A cheap diabetes drug that's been around for 100 years is helping people with type 1 diabetes use significantly less insulin each day. Scientists are now racing to understand why it works so they can help even more patients.
Nearly 5 million Americans with type 2 diabetes are spending less and staying healthier since Medicare capped insulin costs at $35 per month. The policy proves affordable medication saves lives and money.
Groundbreaking therapies combining stem cells and immune drugs are showing real promise in helping people with type 1 diabetes produce their own insulin again. One patient has already delayed disease progression for nearly a decade.
Researchers have cured type 1 diabetes in mice using a breakthrough method that doesn't require lifelong immune-suppressing medications. The innovative technique creates a blended immune system that accepts transplanted insulin-producing cells naturally.
Researchers in Tokyo have discovered a gene that causes dangerous insulin tumors, opening the door to better treatments for patients who suffer life-threatening blood sugar crashes. The breakthrough could transform care for people with insulinomas, tumors that have puzzled doctors for decades.
Scientists created an implant that could free diabetes patients from daily insulin injections. The device keeps insulin-producing cells alive inside the body without needing immune-suppressing drugs.
A new bipartisan bill aims to cap insulin costs at $35 per month for millions with private insurance, building on Medicare protections already in place. The legislation also tackles pharmacy middlemen and aims to boost competition for the life-saving drug. ##
Four senators from both parties are pushing legislation to cap insulin costs at $35 per month for millions of Americans with private insurance. The bill also includes a pilot program to help uninsured patients access affordable insulin.
CVS Caremark has agreed to settle federal charges that it inflated insulin prices, promising changes that could make the lifesaving diabetes medication more affordable. The move follows similar action by another major pharmacy manager, signaling real progress on drug pricing.
Japanese researchers developed a peptide pill that helps insulin survive digestion and enter the bloodstream, potentially ending daily injections for millions with diabetes. The breakthrough could transform diabetes care worldwide, especially in countries like India where treatment access remains challenging.
Researchers have created a groundbreaking pill that could eliminate the need for daily insulin injections for diabetes patients. The innovation promises to transform diabetes management for millions worldwide.
Researchers in Japan have developed an insulin pill that could replace daily injections for millions with diabetes. Early tests in mice showed the oral medication significantly lowered blood sugar with just one dose per day.
A breakthrough study tracking 25,000 people over 14 years reveals the exact amount of sleep that helps prevent type 2 diabetes. The sweet spot? Just over seven hours a night.
Chinese researchers found the sweet spot for preventing diabetes might be getting just over seven hours of sleep each night. The 14-year study of 25,000 people reveals consistent sleep matters more than catching up on weekends.
Your fitness tracker could soon warn you about diabetes years before a blood test would catch it. Scientists discovered that everyday health data reveals hidden signs of insulin resistance that traditional testing completely misses.
University of Chicago scientists developed a breakthrough mRNA therapy that protects insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts. Early tests in animals show the treatment successfully shields the cells that the disease destroys.
Scientists created a breakthrough two-part treatment that restores insulin-producing cells and protects them from immune attacks, potentially freeing millions from daily insulin injections. The therapy combines lab-grown cells with engineered immune "bodyguard" cells.
Adults with cystic fibrosis-related diabetes needed significantly less insulin after one year on Kaftrio, offering hope for reduced treatment burden. The French study of 107 patients also found more stable blood sugar levels and dramatic improvements in lung function.
Scientists created a breakthrough mRNA treatment that shields insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts. Early tests in mice show the nanoparticle therapy successfully reached target cells and delayed disease progression.
Researchers are developing a groundbreaking therapy that could free 1.5 million Americans from daily insulin injections by combining lab-grown insulin cells with immune system "bodyguards." The $1 million project aims to create a cure that works without harsh immunosuppressive drugs.
Showing 20 of 35